Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis.
Saved in:
| Title: | Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis. |
|---|---|
| Authors: | Beneforti L; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Chinnici A; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Coniglio ML; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., Papa MR; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy., Punzi L; Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy., Sieni E; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy., De Fusco C; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy. |
| Source: | British journal of haematology [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1234-1237. Date of Electronic Publication: 2024 Jul 10. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38986479 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF<superscript>V600E</superscript> clone in a newborn affected by high-risk Langerhans cell histiocytosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Beneforti+L%22">Beneforti L</searchLink>; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Chinnici+A%22">Chinnici A</searchLink>; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Coniglio+ML%22">Coniglio ML</searchLink>; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22Papa+MR%22">Papa MR</searchLink>; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Punzi+L%22">Punzi L</searchLink>; Department of Translational Medical Sciences, Section of Pediatrics, University Federico II, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22Sieni+E%22">Sieni E</searchLink>; Department of Pediatric Hematology Oncology, Meyer Children's Hospital IRCCS, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22De+Fusco+C%22">De Fusco C</searchLink>; Department of Oncology, Hematology and Cell Therapy, AORN Santobono-Pausilipon, Naples, Italy. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Sep; Vol. 205 (3), pp. 1234-1237. <i>Date of Electronic Publication: </i>2024 Jul 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38986479 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.19637 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1234 Titles: – TitleFull: Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAFV600E clone in a newborn affected by high-risk Langerhans cell histiocytosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Beneforti L – PersonEntity: Name: NameFull: Chinnici A – PersonEntity: Name: NameFull: Coniglio ML – PersonEntity: Name: NameFull: Papa MR – PersonEntity: Name: NameFull: Punzi L – PersonEntity: Name: NameFull: Sieni E – PersonEntity: Name: NameFull: De Fusco C IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2024 Sep Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 205 – Type: issue Value: 3 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |
